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Abstract The vasodilator-stimulated phosphoprotein (VASP)
colocalizes with the ends of stress fibers in cell-matrix and cell-
cell contacts. We report here that bacterially expressed murine
VASP directly interacts with skeletal muscle actin in several test
systems including cosedimentation, viscometry and polymeriza-
tion assays. It nucleates actin polymerization and tightly bundles
actin filaments. The interaction with actin is salt-sensitive,
indicating that the complex formation is primarily based on
electrostatic interactions. Actin binding is confined to the C-
terminal domain of VASP (EVH2). This domain, when
expressed as a fusion protein with EGFP, associates with stress
fibers in transiently transfected cells.
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1. Introduction
The vasodilator-stimulated phosphoprotein VASP was orig-
inally described as a major substrate for cAMP- and cGMP-
dependent protein kinases in human platelets [1], and is
thought to participate in the regulation of platelet aggregation
[2]. This view is supported by recent data showing that in
VASP knock-out mice collagen-induced platelet aggregation
is signi¢cantly altered [3]. Structural data on VASP are still
lacking, but the human protein, comprising 380 amino acids,
is organized in three functional domains: an N-terminal
EVH1 (residues 1^113), a proline-rich central (residues 114^
225) and a C-terminal EVH2 (residues 226^380) domain. A
schematic view of this domain organization is shown in Hu«t-
telmaier et al. [4]. In a variety of cells, VASP was found
localized at the cytoplasmic face of cell-cell and cell-matrix
contact sites, and in vitro data revealed that it is a multiligand
protein interacting with a variety of micro¢lament proteins
which colocalize with VASP in these areas, like zyxin [5],
vinculin [6,7] and pro¢lin [8]. For vinculin, complex formation
with VASP has been demonstrated in living cells and both
proteins have been shown to concentrate in nascent cell-ma-
trix junctions during cell spreading [4]. Actin binding of par-
tially phosphorylated VASP, obtained from human platelets
and as a recombinant protein from insect cells, has been re-
ported [9,10], but the nature of this interaction has not been
investigated in detail.
In this study, we show that bacterially expressed and puri-
¢ed murine VASP, equipped with a his tag, interacts with
muscle actin in a variety of in vitro assays. It acts as a nucle-
ator of actin polymerization, cosediments with prepolymer-
ized actin ¢laments and bundles them tightly. Actin binding
was seen to strongly depend on the ionic strength of the sol-
ution, indicating that complex formation between VASP and
actin is based on electrostatic interactions, and was found to
reside in the EVH2 domain. In ¢broblasts transiently trans-
fected with EGFP (enhanced green £uorescent protein) fusion
proteins, with the EGFP part located at the N-terminus of
either VASP or its domains, the full length protein targeted to
cell-matrix contact sites, while the EVH2 domain decorated
stress ¢bers.
2. Materials and methods
2.1. Cloning of murine VASP and its derivatives
Murine VASP and its EVH1 and EVH2 domains were generated by
PCR using a VASP EST clone (GenBank accession number W45954,
IMAGp 998J10814, RZPD, Berlin). Ampli¢cation primers contained
a 5P EcoRI and a 3P XhoI restriction site for further subcloning into
vectors for expression of recombinant his-tagged proteins in bacteria
(pQE-30, Qiagen, Hilden, Germany) or transfection experiments with
£uorescent proteins in ¢broblasts (pEGFP-C2, Clontech, Palo Alto,
CA, USA). Ampli¢cation primers were designed so that full length
VASP contained amino acids 1^375, EVH1 amino acids 1^113 and
EVH2 amino acids 222^375. In contrast to human VASP, murine
VASP comprises only 375 amino acids based on a four amino acid
deletion in the proline-rich region and a single amino acid deletion in
the EVH2 domain. In addition, sequencing of the murine EST clone
revealed two deviations from the corresponding GenBank entry: ami-
no acid 209 contained alanine (GCA) instead of threonine (ACA) and
amino acid 288 (glutamine) was deleted.
For detection purposes, the vectors encoding his-tagged proteins
were equipped with further tags. To the N-terminus of full length
VASP, an 11 amino acid motif of birch pro¢lin was added (BiPro-
tag) which is speci¢cally recognized by a monoclonal antibody against
this plant protein [11], EVH1 and EVH2 domains were equipped with
a Flag-tag sequence (Sigma, Munich, Germany).
2.2. Protein expression, puri¢cation and analysis
For recombinant expression of his-tagged proteins, Escherichia coli
(M 15) were transformed with the vectors pQE-30-BiPro-VASP, pQE-
30-Flag-EVH1 and pQE-30-Flag-EVH2 and grown in 2UYT medium
at 30‡C. Protein expression was induced and proteins were puri¢ed
essentially as described in the manufacturer’s protocol (Qiagen, Hil-
den, Germany). Additional puri¢cation was achieved by FPLC (Phar-
macia, Uppsala, Sweden) on a Mono S column in 0.05 M sodium
phosphate, pH 6.7, 0.1 M KCl, 20 mM L-mercaptoethanol, 0.46 WM
aprotinin and 100 WM pefabloc SC, using a KCl gradient for protein
elution. Skeletal muscle actin was prepared from acetone powder as
described and used as Mg2-actin [12]. Purity of all protein prepara-
tions was routinely checked by SDS-PAGE and immunoblots using
antibodies against BiPro- and Flag-tag. Protein concentration was
determined by the Bradford method [13].
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2.3. Actin binding assays
For sedimentation assays, 20 WM actin was prepolymerized in bu¡-
er A (0.025 M Na-phosphate, pH 7.0, 1 mM ATP, 0.5 mM EGTA,
0.5 mM dithioerythritol, 2 mM MgCl2, and KCl concentrations vary-
ing between 15 and 150 mM) for 2 h at 37‡C and incubated with
VASP or its domains for 1 h at room temperature. Sedimentation
assays were performed in an airfuge as described [14], with 2 WM actin
as a ¢nal concentration. Supernatants and sediments were analyzed by
SDS-PAGE.
Complex formation of VASP with actin was monitored with
pyrene-labeled actin (10% of the total actin) essentially as described
[15]. After equilibrating puri¢ed actin in bu¡er B (0.025 M HEPES,
pH 7.0, 0.2 mM CaCl2, 0.5 mM DTE, 1 mM ATP) for 30 min at
25‡C, VASP or its domains were added and polymerization was
started by adjusting the solution to 0.025 M NaCl, 2 mM MgCl2,
and KCl concentrations between 15 and 150 mM. The kinetics of
the reaction were followed for 1 h. After an additional 12 h, aliquots
from the same samples were used for sedimentation at 100 000Ug
(high speed) in an airfuge or at 12 000Ug in an eppifuge (low speed),
to monitor the presence of F-actin [14] and F-actin bundles [16],
respectively.
Actin ¢lament crosslinking and bundling by VASP and its domains
was probed by low shear viscometry essentially as described [12,17],
with some modi¢cations. Proteins were added to a 3 WM prepolymer-
ized F-actin solution in bu¡er C (0.025 M HEPES, pH 7.0, 0.2 mM
CaCl2, 0.5 mM DTE, 1 mM ATP, 0.025 mM NaCl, 2 mM MgCl2,
KCl (15 mM, 50 mM or 150 mM), 0.46 WM aprotinin and 100 WM
pefabloc SC). Aliquots were transferred to glass capillaries and left to
equilibrate at room temperature overnight. Relative viscosity of the
samples was determined as the time needed for a steel ball to pass a
standard distance in the capillary, and expressed in relation to a con-
trol containing only F-actin. VASP- and EVH2-induced, rhodamine-
phalloidin-labeled actin bundles were obtained and examined essen-
tially as described in [17], except that all components were mixed
before polymerization was induced, and ¢xation was omitted.
2.4. Localization of exogenous VASP and its domains in transfected
cells
NIH 3T3 ¢broblasts were grown in Dulbecco’s MEM supplemented
with 10% fetal calf serum at 10% CO2. For analysis of expression and
localization of exogenous proteins, cells were seeded overnight onto
collagen-coated coverslips and transfected with calcium phosphate
precipitates of the eukaryotic vectors coding for EGFP-VASP con-
structs (pEGFP-C2, Clontech, with corresponding inserts), according
to standard protocols. Forty-eight hours after transfection, cells were
washed three times with phosphate-bu¡ered saline containing 2 mM
MgCl2 and 10% glycerol and ¢xed with the bifunctional membrane-
permeable crosslinker DSP (Pierce, Rockford, IL, USA) for 30 min at
37‡C [18,19]. After additional washing, cells were permeabilized with
0.2% Triton X-100 and excess crosslinker was quenched with 0.2 M
glycine. Counterstaining for F-actin and £uorescence microscopy were
performed as described [4].
3. Results
3.1. Recombinant murine VASP and its isolated C-terminal
domain (EVH2) display salt-dependent actin binding
When mixed with G-actin and pyrenyl-labeled G-actin in
bu¡ers promoting actin polymerization, the bacterially ex-
pressed VASP was shown to increase the £uorescence inten-
sity of the sample (Fig. 1A), in a concentration-dependent
manner (not shown). As the increase in pyrenyl-actin £uores-
cence indicates protein complex formation, the results of these
experiments might re£ect either that VASP forms complexes
with G-actin, or that VASP acts as a nucleator, stabilizing
actin seeds and therefore increasing the velocity of actin pol-
ymerization. As seen in Fig. 1B, the latter interpretation is
Fig. 1. E¡ect of VASP and its domains on the polymerization of actin. A, C, D: Fluorescence spectroscopy, following the polymerization of
pyrenyl-labeled actin in the absence and presence of VASP (A) and the EVH1 (D) and EVH2 (C) domains. Final concentrations of the solu-
tions were 1 WM G-actin, 0.25 WM VASP (A), 1 WM EVH2 (C) or 1 WM EVH1 (D), containing di¡erent KCl concentrations as indicated. The
actin controls (solid lines) were incubated in 15 (D) or 150 (A, C) mM KCl only. The e¡ect of VASP on actin £uorescence is stronger than
that of EVH2, while EVH1 is ine¡ective. Note the di¡erence in ordinate scale between A/C and D. B: SDS-PAGE analysis of aliquots taken
from A after 12 h additional incubation. Coomassie-stained actin bands are shown in the pellets (p) and supernatants (s) obtained after high
speed and low speed centrifugation. Note that the fraction of pelletable actin in the presence of VASP (left part of B, low speed centrifugation)
correlates inversely with the salt concentration and that at 15 mM KCl, it is higher than in the actin control. This indicates that the e¡ect of
VASP on actin £uorescence is due to a salt-sensitive nucleating and bundling activity.
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correct: VASP was found to increase rather than decrease the
amount of sedimentable actin in these samples, as compared
with the actin control. A substantial proportion of the ¢la-
ments formed was also sedimented after low speed centrifu-
gation, indicating that bundling of the ¢laments had occurred
(Fig. 1B). As seen in Fig. 1A,B, the interaction of VASP with
actin was found to strongly depend on the ionic strength of
the bu¡er. At low salt conditions (15 mM KCl, 25 mM NaCl
and 2 mM MgCl2), the e¡ect on actin polymerization kinetics
was much stronger than at higher KCl concentrations (i.e.
using 50 mM KCl as a medium, 150 mM KCl as a high
salt concentration). At low KCl concentrations, a molar ratio
of VASP to actin of 0.25:1 led to a prominent stimulation of
polymerization, approaching saturation levels within 1 h (Fig.
1A). When the N- and C-terminal domains of VASP, EVH1
and EVH2, were probed separately with respect to their in-
teraction with actin, only the EVH2 domain was found to be
reactive (Fig. 1C). Its in£uence on pyrenyl-actin £uorescence
was signi¢cantly lower than that of the full length protein. At
1 WM concentrations of both EVH2 and actin (i.e. equimolar
amounts), the e¡ect on £uorescence was still less prominent
than that measured for VASP at one fourth of this concen-
tration (compare Fig. 1A with C), but again the interaction
with actin was strongly salt-dependent. The EVH1 domain
did not display actin binding activity in this assay (Fig. 1D).
The polymerization velocity of the actin control itself was also
salt-dependent, being slightly slower at high KCl values than
at lower ones (not shown), but this e¡ect was negligible in
comparison with the e¡ect of VASP and EVH2 on actin pol-
ymerization.
3.2. Recombinant VASP and the EHV2 domain bind to actin
¢laments in a salt-dependent manner
Binding of recombinant murine VASP and its domains to
prepolymerized F-actin was analyzed using rabbit skeletal
muscle actin in sedimentation assays. Fig. 2 shows the protein
composition of supernatants and pellets obtained after high
speed centrifugation of equimolar mixtures of F-actin and
VASP, EVH1 or EVH2, in the presence of increasing KCl
concentrations (15 mM, 50 mM or 150 mM). Recombinant
VASP (Fig. 2A) and EVH2 (Fig. 2B) cosedimented with pre-
formed F-actin under low salt conditions, demonstrating that
VASP and its EVH2 domain not only interact with F-actin
during polymerization (cf. Fig. 1A,C), but also interact with
preexisting ¢laments. Under the same bu¡er conditions, less
EVH2 sedimented with actin as compared to VASP (cf. Fig.
2A with B), suggesting that EVH2 binding to F-actin may be
less e⁄cient than that of full length VASP. Increasing the KCl
concentrations reduced the amount of both proteins cosedi-
menting with actin (Fig. 2A,B). As already seen in the £uo-
rescence assay with pyrenyl-actin, the EVH1 domain showed
no actin binding activity (Fig. 2C).
3.3. Recombinant VASP and EVH2 bundle actin ¢laments
The nature of the binding of VASP to F-actin was further
analyzed by low shear viscometry, using a falling ball viscom-
eter. Prepolymerized actin, used as a control, displays a high
viscosity (relative viscosity 1.0, Fig. 3A), due to F-actin net-
work formation. At low KCl concentrations, and in the pres-
ence of increasing amounts of either VASP or EVH2, this
viscosity value decreases dramatically, with EVH2 being
somewhat less e¡ective than intact VASP (Fig. 3A). At a
molar ratio of 0.2:1 (VASP/EVH2:actin), the relative viscosity
was only approximately one tenth of that of the actin control,
and at the ratio of 0.5:1, the relative viscosity approached
extremely low levels. In contrast, the EVH1 domain showed
only a slight e¡ect on the actin viscosity (Fig. 3A), con¢rming
also in this assay the results obtained by £uorescence spectros-
copy and sedimentation.
Salt dependence of the actin bundling activity of VASP and
EVH2 was determined as shown in Fig. 3B. Under low salt
conditions, at molar ratios where the low shear viscosity of a
mixture of VASP or EVH2 with actin was very low (0.3:1),
increasing KCl concentrations were found to positively corre-
late with an increase in viscosity. At high ionic strength, the
relative viscosity of the samples was only slightly lower than
that of the actin control, indicating that under these condi-
tions, little VASP/EVH2 was bound to F-actin. As expected
from the results described above, the EHV1 domain had no
substantial e¡ect on actin viscosity at di¡erent salt conditions
(not shown).
Since the sedimentation assays clearly showed that neither
VASP nor EVH2 interferes with the integrity of actin ¢la-
ments, the VASP/EVH2-induced decrease in F-actin viscosity
does not re£ect fragmentation or depolymerization of actin.
Fig. 2. Sedimentation assays of prepolymerized F-actin (2 WM) with
2 WM VASP (A), 2 WM EHV2 (B) and 2 WM EVH1 (C). The sam-
ples were adjusted to the di¡erent KCl concentrations as indicated,
centrifuged, and pellets and supernatants were processed for SDS-
PAGE. VASP as well as EVH2 cosediment with F-actin, while
EVH1 does not. Complex formation is most e⁄cient at low KCl
concentration, and VASP binds more e⁄ciently than EVH2. C:
Control samples without actin, to demonstrate that sedimentation
of the recombinant proteins alone is negligible.
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Instead, it indicates the formation of tight actin bundles which
retain the falling ball much less than the F-actin control. This
has been shown previously for Mg2 actin paracrystals, and
for actin bundles induced by vinculin and K-actinin [12,17,20].
When we examined rhodamine-phalloidin-labeled actin ¢la-
ments, formed in the presence of either VASP or EVH2, by
£uorescence microscopy, the bundles were easily visualized
(Fig. 3C,D), while the actin control showed a ¢ne network
instead (Fig. 3E). Hence, VASP and the EVH2 domain both
display a potent actin bundling activity. However, the mor-
phology of the bundles di¡ered between VASP and the EVH2
domain: VASP induced numerous star-like aggregates, with
short bundles radiating from a distinct center (Fig. 3C, arrow-
heads), while EVH2 led to the formation of long, £exible
bundles (Fig. 3D).
3.4. In transfected cells, exogenous VASP and EVH2 are both
associated with the micro¢lament system but target to
di¡erent locations
The results of the in vitro experiments described above
suggested a salt-dependent and therefore primarily electro-
static interaction between VASP and actin ¢laments, residing
mainly or exclusively in the EVH2 domain. To characterize
such interactions under more physiological conditions, we
transiently transfected 3T3 ¢broblasts with VASP, EVH1
and EVH2 bearing a GFP variant (EGFP) at their N-termini,
Fig. 3. Formation of actin bundles by VASP and EVH2. A, B: Low shear viscometry of prepolymerized actin (3 WM) in the presence and ab-
sence of VASP, EVH1 and EVH2, as indicated. The relative viscosity of the actin control (solid line in A) is set at 1.0. A: Viscosity as a func-
tion of VASP and EVH1/EVH2 concentration. Note the dramatic decrease of viscosity already at very low concentrations of VASP or EVH2,
in contrast to the high viscosity in the presence of EVH1. B: Viscosity as a function of the salt conditions, measured with mixtures of prepo-
lymerized actin (3 WM) and 1 WM VASP or EVH2. Note the prominent salt dependence of the low shear viscosity. C^E: Fluorescence micro-
scopy of TRITC-phalloidin-labeled actin ¢laments, polymerized in the presence of the indicated proteins. Note the strong bundling activity of
both VASP and EVH2, explaining the drastic decrease in viscosity (A), in contrast to the web-like texture of the F-actin control (E). For the
di¡erence in morphology between the bundles in C and D, see text. Bar: 10 Wm.
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which allows direct detection of the exogenous proteins in the
host cells. We then analyzed the localization of the exogenous
protein in ¢xed cells by £uorescence microscopy. Fig. 4 shows
the results of such experiments. Full length VASP (Fig. 4A)
targeted primarily to the ends of stress ¢bers at focal contact
sites, in accordance with the high concentration of the endog-
enous protein seen at the same sites in non-transfected cells
(cf. [4,9]). In contrast, the transfected EVH2 domain deco-
rated stress ¢bers along their entire length (Fig. 4B), but
was not seen in cell adhesion sites, as con¢rmed by counter-
staining for zyxin (data not shown). In general, stress ¢bers in
cells expressing high levels of the EVH2 domain appeared
thicker than in control or VASP-transfected cells. The exoge-
nous EVH1 domain was seen rather homogeneously distrib-
uted throughout the cytoplasm and the nucleus (Fig. 4C).
Only occasionally, in well spread cells expressing moderate
levels of the protein, a weak staining of stress ¢ber ends at
some focal contacts was seen (Fig. 4C, inset).
4. Discussion
In this study we present a detailed analysis of the interac-
tion of bacterially expressed murine VASP with actin. For the
in vitro assays, we used his-tagged VASP rather than a GST-
fusion protein, to avoid a possible in£uence of the GST part
on protein interactions. Furthermore, by using the recombi-
nant protein, we could exclude the in£uence of posttransla-
tional modi¢cation of VASP on the interaction with actin. In
previous reports [9,10], a mixture of unphosphorylated and
phosphorylated VASP was used to show F-actin binding.
Fig. 4. Fluorescence microscopy of 3T3 ¢broblasts transiently transfected with EGFP-fusion proteins of VASP, EVH1 and EVH2. Double £uo-
rescence images for EGFP-VASP (A), EGFP-EVH2 (B) and EGFP-EVH1 (C) are shown, where F-actin is counterstained with rhodamine phal-
loidin (AP, BP, CP). The arrowheads point to the regions enlarged in the insets. Note the targeting of VASP to focal contact sites (A,AP), the
homogeneous decoration by EVH2 (B,BP) of stress ¢bers which appear thicker than normal (cf. the transfected cells in BP with AP and CP), and
the rather homogeneous distribution of EVH1 (C,CP), with an occasional weak decoration of stress ¢ber ends at a focal contact (small arrow-
head, inset in C,CP). Bar: 10 Wm.
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A prominent nucleating activity of VASP during actin pol-
ymerization was revealed by £uorescence spectroscopy in
combination with sedimentation assays, but this method
does not answer the question whether VASP binds solely to
actin in the F-conformation (as for example present in actin
nuclei and ¢laments), or, additionally, to G-actin. Both may
be possible, but VASP is certainly primarily an F-actin nucle-
ating protein, not a G-actin sequestering protein.
VASP binds to preformed actin ¢laments and organizes
them into tight bundles. This was already concluded from
sedimentation [9,10] and turbidity measurements [10], but a
detailed analysis of the bundling activity as a function of the
VASP:actin ratio and the ionic strength of the bu¡er has not
been presented. Our data show that both VASP and its iso-
lated actin binding domain EVH2 induce F-actin bundles,
when present during actin polymerization. VASP, being the
more e¡ective nucleator, organizes actin ¢laments into star-
like aggregates, while EVH2 aligns the ¢laments into parallel
bundles.
For actin bundling proteins in general, two alternative
mechanisms can be envisioned. According to the conventional
mode, bundling proteins also display a ¢lament crosslinking
activity, either due to more than one actin binding motif per
polypeptide, or due to dimer or oligomer formation between
polypeptides comprising one actin binding motif each. Vincu-
lin, which has two actin binding motifs, and K-actinin, which
is a homodimer with one actin binding site per polypeptide
chain, are examples of this case, and both these proteins show
a crosslinking activity at low molar ratios to actin (0.2:1 for
K-actinin, and 0.5:1 for vinculin) but a bundling activity seen
at ratios above these values [12,17,20]. Vinculin-actin com-
plexes are stably formed within a wide range of bu¡ers of
di¡erent ionic strengths, indicating that this interaction does
not primarily depend on ionic interactions [14].
The alternative mode for bundling does not require more
than one actin binding motif but creates ¢lament bundles by
electrostatic interactions between a basic motif of the bun-
dling protein and the acidic actin subunits in the ¢lament.
In this case, the interactions neutralize surface charges at
the ¢laments, which is apparently su⁄cient for bundling and
does not require crosslinking. In this context, it is noteworthy
that VASP and EVH2 both are very e¡ective in actin bun-
dling and show no crosslinking activity, as revealed by the
steep decrease of low shear viscosity already at very low ratios
to actin (0.01:1, see Fig. 3A). An example of a protein bun-
dling ¢laments solely by electrostatic interaction is the smooth
muscle protein calponin which, quite similar to VASP, nucle-
ates actin polymerization and bundles ¢laments in a strictly
salt-dependent manner [16]. In low salt bu¡ers, i.e. under
conditions in which it interacts with actin, calponin is mono-
meric [21]. For VASP, information on its molecular state in
solution or when bound to actin is still lacking. It has been
reported that puri¢ed VASP exists as a tetramer [22], but in
our hands monomeric, dimeric, tetrameric and higher aggre-
gates were found after chemical crosslinking of VASP in sol-
ution as well as in cells (data not shown). Due to these ob-
servations, one might wonder whether the electrostatic
interaction might indeed be con¢ned to the interaction with
actin, or involve also a VASP oligomerization process. As the
ratio of oligomeric products obtained after chemical crosslink-
ing of puri¢ed VASP was not a¡ected by increasing the KCl
concentration from 15 to 150 mM (data not shown), we sug-
gest that it is indeed primarily the complex formation with
actin which is sensitive to high ionic strength. VASP displays
an isoelectric point (IEP) of 8.53, and the EVH2 domain an
IEP of 8.1, which would be su⁄cient for a strong electrostatic
interaction with actin, but the EVH1 domain, which proved
inactive in our assays, is even more basic, showing an IEP of
9.4 (our own unpublished data).
However, these considerations do not preclude the possibil-
ity that small basic clusters, surface exposed within a larger
domain of any IEP, might mediate electrostatic actin binding.
While our data demonstrate that the EVH2 domain alone, in
contrast to EVH1, has actin binding and bundling activity, we
cannot exclude further actin binding motifs in the VASP se-
quence, for example within the central proline-rich domain.
This portion of the VASP molecule is unstable and cannot be
isolated from bacteria as a discrete entity. The weaker nucle-
ating e¡ect of the EVH2 domain on actin, as compared to the
full length VASP, and the observed di¡erence in VASP-actin
and EVH2-actin bundle morphology, may re£ect some regu-
latory in£uence of the intact protein on the activity of this
domain.
In an attempt to compare the in vitro binding capacity of
VASP with a more physiological situation, we examined the
possible association of VASP and the EVH domains with
actin ¢laments in transfected cells. 3T3 ¢broblasts expressed
the respective GFP-tagged constructs and could thus be used
to analyze the targeting of the exogenous proteins. Full length
VASP was seen concentrated in focal contacts, in accordance
with the location of the endogenous protein, but was not seen
along stress ¢bers. This may re£ect the fact that the N-termi-
nal EHV1 domain of VASP, when present in the intact pro-
tein, interacts with two focal contact proteins, vinculin [6] and
zyxin [5], and that these interactions may be of higher a⁄nity
than that with actin. Alternatively or additionally, ligand
binding activities of VASP may be subject to regulatory mech-
anisms, for example by phosphorylation.
The exogenous EVH2 domain was clearly seen to decorate
stress ¢bers. Even in cells expressing this fragment to very
high levels, we did not observe a gross reorganization of ¢la-
mentous actin into abnormal tangles or needles, as for exam-
ple observed in cells transfected with the vinculin actin bind-
ing fragment [12]. We cannot exclude that the stress ¢ber
decoration by the EHV2 domain involves binding to stress
¢ber constituents other than F-actin. However, the observa-
tion that, in general, stress ¢bers in EVH2-transfected cells
appeared thicker than normal suggests a direct interaction
between EVH2 and F-actin, resulting in actin ¢lament bun-
dling comparable to that seen in vitro. Thickening of stress
¢bers might then indicate the recruitment of ¢lamentous actin
to the preexisting ¢bers by electrostatic interactions, in a zip-
per-like mechanism. Further analysis of this phenomenon
with mutant domains is in progress.
Considering the prominent salt sensitivity of the interaction
of VASP and EVH2 with actin, as observed in vitro, the
observed association of both these proteins with actin ¢la-
ments at the physiological ionic strength in cells remains to
be explained. In this context, it should be mentioned that
calponin, which in vitro bundles F-actin also exclusively at
low ionic strength [16], was found associated with the actin
cytoskeleton in activated platelets and with stress ¢bers in
¢broblasts [23], and with the contractile and cytoskeletal com-
partment of smooth muscle cells [23,24]. For this protein, it
FEBS 22007 10-5-99
S. Hu«ttelmaier et al./FEBS Letters 451 (1999) 68^74 73
has been proposed that the local concentration of actin and
calponin within such structures may be su⁄ciently high to
allow for complex formation even under the conditions of
the cytoplasm [16]. An analogous explanation may be as-
sumed for VASP.
Acknowledgements: This work was supported by the Deutsche For-
schungsgemeinschaft.
References
[1] Halbrugge, M. and Walter, U. (1990) J. Chromatogr. 521, 335^
343.
[2] Walter, U., Eigenthaler, M., Geiger, J. and Reinhard, M. (1993)
Adv. Exp. Med. Biol. 344, 237^249.
[3] Aszo'di, A. et al. (1999) EMBO J. 18, 37^48.
[4] Hu«ttelmaier, S., Mayboroda, O., Harbeck, B., Jarchau, T., Jock-
usch, B.M. and Ru«diger, M. (1998) Curr. Biol. 8, 479^488.
[5] Reinhard, M., Jouvenal, K., Tripier, D. and Walter, U. (1995)
Proc. Natl. Acad. Sci. USA 92, 7956^7960.
[6] Reinhard, M., Rudiger, M., Jockusch, B.M. and Walter, U.
(1996) FEBS Lett. 399, 103^107.
[7] Brindle, N.P.J., Holt, M.R., Davies, J.E., Price, C.J. and Critch-
ley, D.R. (1996) Biochem. J. 318, 753^757.
[8] Reinhard, M., Giehl, K., Abel, K., Ha¡ner, C., Jarchau, T.,
Hoppe, V., Jockusch, B.M. and Walter, U. (1995) EMBO J.
14, 1583^1589.
[9] Reinhard, M., Halbrugge, M., Scheer, U., Wiegand, C., Jock-
usch, B.M. and Walter, U. (1992) EMBO J. 11, 2063^2070.
[10] Laurent, V., Loisel, T.P., Harbeck, B., Wehman, A., Gro«be, L.,
Jockusch, B.M., Wehland, J., Gertler, F. and Carlier, M.F.
(1999) J. Cell Biol. (in press).
[11] Ru«diger, M., Jockusch, B.M. and Rothkegel, M. (1997) BioTech-
niques 23, 96^97.
[12] Ru«diger, M., Korneeva, N., Schwienbacher, C., Weiss, E.E. and
Jockusch, B.M. (1998) FEBS Lett. 431, 49^54.
[13] Bradford, M.M. (1976) Anal. Biochem. 72, 248^254.
[14] Menkel, A.R., Kroemker, M., Bubeck, P., Ronsiek, M., Nikolai,
G. and Jockusch, B.M. (1994) J. Cell Biol. 126, 1231^1240.
[15] Schlu«ter, K., Schleicher, M. and Jockusch, B.M. (1998) J. Cell
Sci. 111, 3261^3273.
[16] Tang, J.X., Szymanski, P., Janmey, P.A. and Tao, T. (1997) Eur.
J. Biochem. 247, 432^440.
[17] Korneeva, N.L. and Jockusch, B.M. (1996) Eur. J. Cell Biol. 71,
351^355.
[18] Hinck, L., Nathke, I.S., Papko¡, J. and Nelson, W.J. (1994)
J. Cell Biol. 125, 1327^1340.
[19] Weiss, E.E., Kroemker, M., Ru«diger, A.H., Jockusch, B.M. and
Ru«diger, M. (1998) J. Cell Biol. 141, 755^764.
[20] Hu«ttelmaier, S., Bubeck, P., Ru«diger, M. and Jockusch, B.M.
(1997) Eur. J. Biochem. 247, 1136^1142.
[21] Sta¡ord, W.F.I., Mabuchi, K., Takahashi, K. and Tao, T. (1995)
J. Biol. Chem. 270, 10576^10579.
[22] Ha¡ner, C., Jarchau, T., Reinhard, M., Hoppe, J., Lohmann,
S.M. and Walter, U. (1995) EMBO J. 14, 19^27.
[23] Takeuchi, K., Takahashi, K., Abe, M., Nishida, W., Hiwada, K.,
Nabeya, T. and Maruyama, K. (1991) J. Biochem. 109, 311^316.
[24] North, A.J., Gimona, M., Cross, R.A. and Small, J.V. (1994)
J. Cell Sci. 107, 445^455.
FEBS 22007 10-5-99
S. Hu«ttelmaier et al./FEBS Letters 451 (1999) 68^7474
